...A. I we think were trading at about $3 a share and maybe at 30 million shares outstanding. B. This allows us now to deliver tests like Cologuard, like Oncotype DX, which we'll talk about. C. Broadly, the mortality rate for heart disease has dropped 75% over the last 50 years, it's amazing, by focus on earlier detection and prevention. D. Our mission is to do the same thing for cancer, and we started with Cologuard. E. There -- this year, there will be about 150,000 people in the U.S. diagnosed with colon cancer. F. 90% of people with Stage I and II colon cancer survive. G. 10% of people with late-stage, Stage IV colon cancer, survive. H. 6, 7 years ago, we moved on to Epic, which is the most commonly used software EMR system in health systems across the U.S. I. That was all done electronically because we made the $1 billion IT investment that we've made over the last 14 years. J. We've had 10,000 applications for people wanting to join Exact Sciences this year. K. Are you carrying a gene...
